Alexion Pharmaceuticals

$1.4B revenue • 1,001 employees • 801 Pennsylvania Avenue NW #830, Washington, DC, 20004, United States

Company Overview

Company Name

Alexion Pharmaceuticals

Address

801 Pennsylvania Avenue NW #830, Washington, DC, 20004, United States

Approx. Annual Revenue

$1400.0M

Employees

1,001

About Alexion Pharmaceuticals

Alexion, AstraZeneca Rare Disease is a company headquartered in Washington, DC, United States, with approximately 1,001 employees. The company is dedicated to delivering life-changing therapies to people living with rare diseases, focusing on research, development, and innovation in areas such as bone metabolism, cardiology, endocrinology, and more.

Frequently Asked Questions about Alexion Pharmaceuticals

Technologies Used

Social Profiles

Key Decision Makers

Yikun Guo Clinical Trial Manager II
LinkedIn
Cesar Delcompare Clinical Trial Manager II
LinkedIn
Elizabeth Buckley Clinical Trial Manager
LinkedIn
Ashwan Errawalla Clinical Trial Manager
LinkedIn
Thema Marie V. Sr. Clinical Research Associate
LinkedIn
Sharitta Cuttino Senior Clinical Research Associate
LinkedIn
Theodore Wing Senior Clinical Research Associate
LinkedIn
Disha Patel Clinical Trial Manager - II
LinkedIn
Ghaith Mitri Sr. Medical Director, Clinical Development, Rheumatology & Rare Diseases - Neurology & Ophthalmology
LinkedIn
Ron Gugliotti Director of Clinical Development
LinkedIn
Sahar Esteghamat, MSc, PhD Director-Clinical Development Scientist
LinkedIn
Chris Johnson Executive Director, Head of U.S. Sales
LinkedIn